Eqis Capital Management Inc. lowered its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 34.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 15,248 shares of the pharmacy operator’s stock after selling 8,108 shares during the period. Eqis Capital Management Inc.’s holdings in Walgreens Boots Alliance were worth $965,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of WBA. CSat Investment Advisory L.P. lifted its holdings in Walgreens Boots Alliance by 12.1% during the 4th quarter. CSat Investment Advisory L.P. now owns 1,920 shares of the pharmacy operator’s stock worth $131,000 after buying an additional 208 shares during the period. Pathlight Investors LLC acquired a new position in Walgreens Boots Alliance during the 4th quarter worth about $524,000. James Investment Research Inc. acquired a new position in Walgreens Boots Alliance during the 4th quarter worth about $963,000. Tiemann Investment Advisors LLC lifted its holdings in Walgreens Boots Alliance by 2.7% during the 4th quarter. Tiemann Investment Advisors LLC now owns 22,190 shares of the pharmacy operator’s stock worth $1,516,000 after buying an additional 586 shares during the period. Finally, Newman Dignan & Sheerar Inc. lifted its holdings in Walgreens Boots Alliance by 22.9% during the 1st quarter. Newman Dignan & Sheerar Inc. now owns 4,616 shares of the pharmacy operator’s stock worth $292,000 after buying an additional 861 shares during the period. Institutional investors and hedge funds own 65.05% of the company’s stock.

In other news, COO Ornella Barra bought 18,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was acquired at an average cost of $54.56 per share, with a total value of $982,080.00. Following the transaction, the chief operating officer now directly owns 26,425 shares of the company’s stock, valued at approximately $1,441,748. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 15.73% of the company’s stock.

WBA has been the topic of several recent research reports. BidaskClub downgraded Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a report on Thursday, December 27th. UBS Group initiated coverage on Walgreens Boots Alliance in a report on Thursday, January 17th. They set a “sell” rating and a $70.00 target price on the stock. Loop Capital set a $82.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 23rd. Zacks Investment Research downgraded Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a report on Tuesday, February 26th. Finally, Robert W. Baird cut their target price on Walgreens Boots Alliance from $70.00 to $67.00 and set a “neutral” rating on the stock in a report on Friday, March 1st. Five analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $68.00.

Shares of NASDAQ:WBA opened at $54.63 on Friday. The stock has a market capitalization of $49.95 billion, a PE ratio of 9.07, a price-to-earnings-growth ratio of 1.11 and a beta of 0.86. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.38 and a current ratio of 0.78. Walgreens Boots Alliance Inc has a 1 year low of $53.32 and a 1 year high of $86.31.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Tuesday, April 2nd. The pharmacy operator reported $1.64 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.70 by ($0.06). The business had revenue of $34.53 billion during the quarter, compared to analyst estimates of $34.57 billion. Walgreens Boots Alliance had a net margin of 3.77% and a return on equity of 22.00%. The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.73 earnings per share. On average, equities research analysts forecast that Walgreens Boots Alliance Inc will post 5.99 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Monday, May 20th will be given a $0.44 dividend. This represents a $1.76 dividend on an annualized basis and a yield of 3.22%. The ex-dividend date of this dividend is Friday, May 17th. Walgreens Boots Alliance’s payout ratio is 29.24%.

COPYRIGHT VIOLATION NOTICE: This news story was first posted by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was illegally stolen and reposted in violation of United States and international copyright laws. The legal version of this news story can be read at https://www.watchlistnews.com/eqis-capital-management-inc-trims-position-in-walgreens-boots-alliance-inc-wba/2979132.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Dividend Achievers

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.